sellModerate cluster of 4
Riccardo Perfetti sold $597k of APLT
Chief Medical Officer at Applied Therapeutics, Inc.. 110,804 shares at an average of $5.39, traded Mar 14, 2024, filed Mar 18, 2024.
Warning score
49Value
$597k
110,804 shares
Holdings after
1,031,537
-10% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +19Trade size$597k at market
- 0Share of holdings soldSold 9.7% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001096906-24-000495, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 14, 2024 | SOpen-market sale Common Stock | -110,804 | $5.39 | $597k | 1,031,537 | Mar 18, 2024 |
Related signals
Other insiders at Applied Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | APLTsell Applied Therapeutics, Inc. | Stacy J. Kanter director | $4,816 43,000 shares | -40% | |
| 30Weak | Applied Therapeutics, Inc. | Constantine Chinoporos See Remarks | $197 447 shares | -0% | |
| 30Weak | Applied Therapeutics, Inc. | Leslie D. Funtleyder See Remarks | $6,381 14,502 shares | -4% | |
| 30Weak | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $4,561 10,366 shares | -1% | |
| 30Weak | Applied Therapeutics, Inc. | Constantine Chinoporos See Remarks | $17k 28,117 shares | -9% | |
| 37Weak | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $53k 86,078 shares | -9% | |
| 30Weak | Applied Therapeutics, Inc. | Leslie D. Funtleyder See Remarks | $14k 22,950 shares | -5% | |
| 37Weak | APLTsell Applied Therapeutics, Inc. | Alexandria Real Estate Equities, Inc. owner | $1.3M 300,000 shares | -5% | |
| 48Moderate | Applied Therapeutics, Inc. | Leslie D. Funtleyder Chief Financial Officer | $155k 28,727 shares | -9% | |
| 43Moderate | Applied Therapeutics, Inc. | Adam Hansard Chief Commercial Officer | $263k 48,871 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.